Serostim

Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for HIV-associated wasting.[1]

In December 2007, the U.S. District Court of Massachusetts - in a class-action lawsuit that involved Merck Serono and Serostim - fined Serono a total of $704 million in criminal and civil liabilities for enacting "illegal schemes to promote, market and sell its drug."[2]

References

  1. ^ "Serostim® (somatropin) For Injection | Website For Patients". Serostim.
  2. ^ "SERONO TO PAY $704 MILLION FOR THE ILLEGAL MARKETING OF AIDS DRUG". Department of Justice. 17 October 2005. Retrieved 23 June 2018.

External links

  • Settlement infoi
  • v
  • t
  • e
Merck Serono
Products
  • Avelumab
  • Bisoprolol
  • Cetuximab
  • Cladribine
  • Efalizumab
  • Gonadotropin preparations
  • Human chorionic gonadotropin
  • Interferon beta-1a
  • Levothyroxine
  • Luteinizing hormone
  • Metformin
  • Mitoxantrone
  • Saizen
  • Serostim
  • Tegafur/uracil
Related


Stub icon

This hormonal preparation article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e